Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP617324.RABmId2E-LNjI2qn2Wg5ziuhsz3GgKnlQfdlmOR-o-jf4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP617324.RABmId2E-LNjI2qn2Wg5ziuhsz3GgKnlQfdlmOR-o-jf4130_assertion type Assertion NP617324.RABmId2E-LNjI2qn2Wg5ziuhsz3GgKnlQfdlmOR-o-jf4130_head.
- NP617324.RABmId2E-LNjI2qn2Wg5ziuhsz3GgKnlQfdlmOR-o-jf4130_assertion description "[Taken together, these data provide proof of principle that the progesterone receptor of myelin-forming Schwann cells is a promising pharmacological target for therapy of CMT-1A.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP617324.RABmId2E-LNjI2qn2Wg5ziuhsz3GgKnlQfdlmOR-o-jf4130_provenance.
- NP617324.RABmId2E-LNjI2qn2Wg5ziuhsz3GgKnlQfdlmOR-o-jf4130_assertion evidence source_evidence_literature NP617324.RABmId2E-LNjI2qn2Wg5ziuhsz3GgKnlQfdlmOR-o-jf4130_provenance.
- NP617324.RABmId2E-LNjI2qn2Wg5ziuhsz3GgKnlQfdlmOR-o-jf4130_assertion SIO_000772 14608378 NP617324.RABmId2E-LNjI2qn2Wg5ziuhsz3GgKnlQfdlmOR-o-jf4130_provenance.
- NP617324.RABmId2E-LNjI2qn2Wg5ziuhsz3GgKnlQfdlmOR-o-jf4130_assertion wasDerivedFrom befree-20150227 NP617324.RABmId2E-LNjI2qn2Wg5ziuhsz3GgKnlQfdlmOR-o-jf4130_provenance.
- NP617324.RABmId2E-LNjI2qn2Wg5ziuhsz3GgKnlQfdlmOR-o-jf4130_assertion wasGeneratedBy ECO_0000203 NP617324.RABmId2E-LNjI2qn2Wg5ziuhsz3GgKnlQfdlmOR-o-jf4130_provenance.